<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-pharmaceuticals-12-00060">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Smith</surname>
    <given-names>D.R.</given-names>
   </name>
   <name>
    <surname>Hollidge</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Daye</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Zeng</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Blancett</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Kuszpit</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Bocan</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Koehler</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>Coyne</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Minogue</surname>
    <given-names>T.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon</article-title>
  <source>PLoS Negl. Trop. Dis.</source>
  <year>2017</year>
  <volume>11</volume>
  <elocation-id>e0005296</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pntd.0005296</pub-id>
  <?supplied-pmid 28068342?>
  <pub-id pub-id-type="pmid">28068342</pub-id>
 </element-citation>
</ref>
